Research On Cost Management Of M Enterprise Based On Value Chain Theory

With the imple entation of China's maritime power and The Belt and Road "strategy,marine biological pharmaceutical industry as a strategic measure to realize the upgrading of blue economic development," 12 th Five-Year "plan has been included in the 7 strategic emerging industries and one of the pillar industries.At the same time,the 2016 "cost reduction" is listed as one of the five major tasks of the supply side structural reform,which reflects the central enterprises in lowering the efficiency of attention,however most of the current cost control in China's marine biological pharmaceutical enterprises still focus on reducing the costs of manufacturing products,suppliers and ignore the interests of buyers,not conducive to the long-term development of enterprises.This paper selects the typical marine biological pharmaceutical enterprise M company as the research object,the integrated use of the methods of historical study and literature review method,qualitative and quantitative analysis method,field investigation method,based on value chain theory of cost management in M.In this paper,firstly,explaining the research background and significance of the topic,studies the domestic and foreign research on the value chain theory and the value chain cost management theory.Secondly,based on the analysis of value chain cost management theory,combined with the problems existing in the research,procurement,production,sales and other aspects of M company,constructing the value chain cost management system for M company in order to achieve a win-win situation on the value chain.Finally,the safeguard measures are presented.Through the study of value chain cost management of M company,draw the following conclusion: firstly the company should use activity-based costing and target costing accounting as the main tool of internal value chain cost management,effectively identify value-added operations and non value-added operations,to eliminate non value added activity,reduce the waste of resources;secondly,the company shoud fully consider the efficacy and economy of drug,with the target cost as a measure of the standard,and make full use of internal and external resources,reduce costs as much as possible;the last is to classify and select suppliers,vendors,and establish a good strategic partnership,information sharing,reasonable transportation docking,in order to optimize the whole value chain.